Back to Agenda
How to Provide Necessary Medicinal Products to Children?
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
In this session, speakers share the efficacy of exsiting pediatric regulation and discuss future collaboration to promote pediatric drug development worldwide
Learning Objective : Describe the pediatric regulation of Japan, US and engagement of emerging counties; Discuss collaboration to promote pediatric drug development in these countries.
Speaker(s)
PMDA Update
Michiyo Sakiyama, MD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Senior Scientist for Clinical Medicine, Office of Vaccines and Blood
FDA Update
Gerold Wharton
FDA, United States
Program Analyst, Office of Clinical Policy and Programs, OC
How to Provide Necessary Medicinal Products to Children - An Industry Perspective
Robert "Skip" Nelson, MD, PhD
Johnson & Johnson, United States
Executive Director, Pediatric Drug Development (CHILD)
Have an account?